Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 145

Results For "GTHE"

1486 News Found

Swastika Investmart and Medcords Healthcare join hands to finance medical stores
Healthcare | August 18, 2021

Swastika Investmart and Medcords Healthcare join hands to finance medical stores

Through the Sehat Sathi App business can access unsecured business loans at low interest


Novartis secures new approval in China for Cosentyx in pediatric psoriasis
Drug Approval | August 18, 2021

Novartis secures new approval in China for Cosentyx in pediatric psoriasis

Cosentyx is a proven treatment, supported by long-term five-year sustained efficacy and safety data across several inflammatory conditions and with more than 500,000 patients treated worldwide since launch


One more lab approved for batch-testing and release of Covid-19 vaccines
News | August 17, 2021

One more lab approved for batch-testing and release of Covid-19 vaccines

National Institute of Animal Biotechnology, Hyderabad can now conduct quality checks and consequent lot release of Covid-19 vaccines


Centre allocates Rs 267.35 crores to Kerala for Covid response
Policy | August 17, 2021

Centre allocates Rs 267.35 crores to Kerala for Covid response

Rs one crore for each district to create medicine pool and support Centre of Excellence for Telemedicine


SCHOTT and Serum Institute announce JV for pharma packaging
Packaging | August 17, 2021

SCHOTT and Serum Institute announce JV for pharma packaging

Serum buys 50 per cent stake in Indian joint venture of SCHOTT Kaisha


Syngene sets up microbial facility as it expands biopharma-manufacturing capacity
Biotech | August 13, 2021

Syngene sets up microbial facility as it expands biopharma-manufacturing capacity

It strengthens Syngene’s portfolio as a fully integrated custom biomanufacturer with added mammalian and microbial capabilities for clinical and commercial supplies


GSK files application for MMR vaccine in the US
News | August 11, 2021

GSK files application for MMR vaccine in the US

If approved it will bring a second source of MMR vaccine to the US market


Sequent Scientific net profit at Rs 87.30 lakh in Q1FY22
News | August 11, 2021

Sequent Scientific net profit at Rs 87.30 lakh in Q1FY22

Formulation business grew by 15 per cent in the quarter


QIAGEN and OncXerna Therapeutics sign licensing and master companion diagnostic agreements
Drug Approval | August 10, 2021

QIAGEN and OncXerna Therapeutics sign licensing and master companion diagnostic agreements

QIAGEN and OncXerna enter into a global master agreement to advance the development of the Xerna TME panel as a potential Next Generation Sequencing (NGS) companion diagnostic for OncXerna’s Navicixizumab


Cipla posts  net profit at Rs 715 crores
News | August 08, 2021

Cipla posts net profit at Rs 715 crores

India business contributes to a stellar performance